With EU Unitary Patent Sealed, All Eyes Are On New Patent Court
This article was originally published in Scrip
The final step in creating a unitary patent system in Europe has been taken with the completion of a legal framework containing the implementing and financial rules for the new patent as well as the rules governing the level of renewal fees and the distribution of the fees among the European Patent Office and the participating member states.
You may also be interested in...
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.
With product shortages made worse by the pandemic, companies in the UK are being asked to use a new system for notifying potential supply disruptions and any plans to discontinue specific medicines.